Matthew G. Clark | Joint Project Manager, CBRN Medical
JPEO-CBRND

Matthew G. Clark, Joint Project Manager, CBRN Medical, JPEO-CBRND

Colonel Matthew G. Clark is the Joint Project Manager for Chemical, Biological,
Radiological, and Nuclear Medical (JPM CBRN Medical). He is responsible for leading the
medical portfolio for the Joint Program Executive Office for Chemical, Biological,
Radiological and Nuclear Defense (JPEO-CBRND).
COL Clark previously served as Senior Policy Advisor and Director of COVID-19
International Response Operations on the White House COVID-19 Response Team
(WHCRT), after serving as the Lead Program Manager for the vaccine team in Operation
Warp Speed. He was on hiatus from serving as the Director of the Office of Medical
Systems under the Assistant Secretary of the Army for Acquisition, Logistics, and
Technology. On the WHCRT, he led operations to move 1.2+ billion COVID-19 vaccines
to 115 countries bilaterally and through: COVID-19 Vaccines Global Access, involving
Gavi (The Vaccine Alliance); the World Health Organization; the United Nations Children's
Fund; the Pan American Health Organization global organizations; and the African
Vaccine Acquisition Trust, via the African Union. He worked the whole-of-government
vaccine response through: the U.S. Department of Health and Human Services
Coordination Operation Response Element (formerly the Countermeasures Acceleration
Group); the Departments of State and Defense; the U.S. Agency for International
Development; the National Institutes of Health; the U.S. Food and Drug Administration;
the Centers for Disease Control and Prevention; and the Federal Emergency
Management Agency. The public-private team he led delivered over 534 million doses.
COL Clark previously served as Joint Product Manager for Chemical Defense
Pharmaceuticals in the JPEO-CBRND. His team received a Gold-level Edison Award™ of
Innovation for high-quality, rapid product development for tightly-engineered capabilities,
published in four Army AL&T Magazine articles; and received MG Harry Greene Awards
in 2018 and 2019. He was also the first medical officer recognized as the U.S. Army’s
Product Manager of the Year in 2018. In other leadership positions around the world, he
directed medical clinics and laboratories, served as Military Legislative Assistant in the
U.S. House of Representatives, and as the Director of the Eisenhower Leader
Development Program at the U.S. Military Academy at West Point and Columbia
University.
He is a distinguished graduate of Coe College and received a PhD in behavioral and
neural sciences from Rutgers University. He also has a master’s with distinction in
strategic studies from the Army War College, and in 2021, received a doctorate of
humane letters from Coe College. He has published two edited books, eight book
chapters, and over 30 peer-reviewed and professional articles.

Appearances:



WVIC/WAC Day 2 - Nov 30 @ 11:30

Chair’s opening remarks

WVIC/WAC Day 3 - Dec 1 @ 08:30

Panel: Therapeutic approaches to pandemic preparedness

  • Prediction–Predicting the next viral threat and developing a drug with a specific target
  • Broad-spectrum–Developing drugs that work broadly across many stains/viruses
  • Platforms–Warp speed platforms to develop therapeutics once a threat appears
  • What are the advantages and disadvantages of each approach?
last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

lauren.sheppard@terrapinn.com

For sponsorship and exhibition opportunities:
Thomas Hall

thomas.hall@terrapinn.com